Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Ingliforib

Ingliforib (CP 368296) is a glycogen phosphorylase inhibitor, with IC50s of 52, 352 and 150 nM for liver, muscle and brain glycogen phosphorylase, and has cardioprotective activity.

Product Specifications

CAS Number

[186392-65-4]

Product Name Alternative

CP 368296; GPi 296

UNSPSC

12352005

Hazard Statement

H302-H315-H319

Target

Phosphorylase

Type

Reference compound

Related Pathways

Metabolic Enzyme/Protease

Applications

COVID-19-immunoregulation

Field of Research

Cardiovascular Disease

Assay Protocol

https://www.medchemexpress.com/Ingliforib.html

Concentration

10mM

Purity

99.07

Solubility

DMSO : 130 mg/mL (ultrasonic)

Smiles

O=C(C(N1)=CC2=C1C=CC(Cl)=C2)N[C@@H](CC3=CC=CC=C3)[C@@H](O)C(N4C[C@@H](O)[C@@H](O)C4)=O

Molecular Formula

C23H24ClN3O5

Molecular Weight

457.91

Precautions

P264-P270-P280-P302+P352-P305+P351+P338-P330-P362+P364-P501

References & Citations

[1]Tracey WR, et al. Cardioprotective effects of ingliforib, a novel glycogen phosphorylase inhibitor. Am J Physiol Heart Circ Physiol. 2004 Mar;286 (3) :H1177-84.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

(8S,10S,13S,14S,16S,17R) -17- (2-Hydroxyacetyl) -10,13,16-trimethyl-3-oxo-6,7,8,10,12,13,14,15,16,17-decahydro-3H-cyclopenta[a]phenanthren-17-yl pentanoate (Betamethasone Valerate Impurity)
OR1039873-01 50 mg

(8S,10S,13S,14S,16S,17R) -17- (2-Hydroxyacetyl) -10,13,16-trimethyl-3-oxo-6,7,8,10,12,13,14,15,16,17-decahydro-3H-cyclopenta[a]phenanthren-17-yl pentanoate (Betamethasone Valerate Impurity)

Ask
View Details
(8S,10S,13S,14S,16S,17R) -17- (2-Hydroxyacetyl) -10,13,16-trimethyl-3-oxo-6,7,8,10,12,13,14,15,16,17-decahydro-3H-cyclopenta[a]phenanthren-17-yl pentanoate (Betamethasone Valerate Impurity)
OR1039873-02 100 mg

(8S,10S,13S,14S,16S,17R) -17- (2-Hydroxyacetyl) -10,13,16-trimethyl-3-oxo-6,7,8,10,12,13,14,15,16,17-decahydro-3H-cyclopenta[a]phenanthren-17-yl pentanoate (Betamethasone Valerate Impurity)

Ask
View Details
(8S,10S,13S,14S,16S,17R) -17- (2-Hydroxyacetyl) -10,13,16-trimethyl-3-oxo-6,7,8,10,12,13,14,15,16,17-decahydro-3H-cyclopenta[a]phenanthren-17-yl pentanoate (Betamethasone Valerate Impurity)
OR1039873-03 200 mg

(8S,10S,13S,14S,16S,17R) -17- (2-Hydroxyacetyl) -10,13,16-trimethyl-3-oxo-6,7,8,10,12,13,14,15,16,17-decahydro-3H-cyclopenta[a]phenanthren-17-yl pentanoate (Betamethasone Valerate Impurity)

Ask
View Details
SCARA5
575643-01 50 µg

SCARA5

Ask
View Details
SCARA5
575643-02 100 µg

SCARA5

Ask
View Details
Recombinant Human CEACAM6/CD66c Protein
RP00413-01 100 μg

Recombinant Human CEACAM6/CD66c Protein

Ask
View Details